René Gantier, PhDDirector of Technology, Gene Therapy at Repligen
Mr. René Gantier is currently the Director of Technology for Gene Therapy at Repligen. He brings nearly 20 years’ experience developing production and purification processes for biotherapies. He started his career in the biotechnology industry as a scientist, developing long-lasting therapeutic cytokines at Nautilus Biotech in France before joining Pall Life Sciences as a downstream processing field application specialist. He expanded his role to lead the Biotech Process R&D team developing end-to-end upstream-downstream continuous bioprocessing solutions for mAbs and cell/gene therapies. His primary role at Repligen is to provide technology guidance in the development of high productivity, next generation gene therapy manufacturing processes. René holds a MSc in Cell Biology from the University of Nantes France, and a PhD in Biochemistry from the University of Rouen, France.